Published on 13 Jan 2021

Indonesia’s president receives a Chinese-made vaccine that produced disappointing trial results

The New York Times

Indonesia, which authorised emergency use of the Sinovac vaccine on Monday, had previously ordered 125.5 million doses from the company and lesser amounts from several others. But there are still questions around the Sinovac vaccine, which China began administering last year before human trials were completed. Sulfikar Amir, an Indonesian associate professor of disaster sociology at NTU in Singapore, said Indonesia appeared to be hurrying the vaccine into use rather than doing a better job with social restrictions, testing and tracing.

Read the article here

Photo: Hakan Nural on Unsplash